Barclays
ENZN

Barclays’s ENZON PHARMACEUTICALS INC ENZN Stock Holding History

Barclays’s Portfolio ENZN Stock Details ENZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-36
Closed – – 7841
2014
Q3 		$0 Sell
36
-77,022
-100% -$95.1K ﹤0.01% 7976
2014
Q2 		$77K Buy
77,058
+5,303
+7% +$5.05K ﹤0.01% 5634
2014
Q1 		$71K Buy
71,755
+47,187
+192% +$48.7K ﹤0.01% 5718
2013
Q4 		$25K Sell
24,568
-27,698
-53% -$42.7K ﹤0.01% 6590
2013
Q3 		$52K Sell
52,266
-9,735
-16% -$18K ﹤0.01% 6042
2013
Q2 		$124K Buy
+62,001
New +$182K ﹤0.01% 5613

Other funds holding ENZN

IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
CSC
Cove Street Capital El Segundo, California $76.6M AUM 36% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Barclays's ENZN Position: Q4 2014 in Review

Barclays sold out of ENZON PHARMACEUTICALS INC (ENZN) in Q4 2014, closing a stake of 36 shares.

Barclays first reported a position in ENZN in Q2 2013 and held it in 6 quarters. The position peaked at $124K in Q2 2013. 57 funds tracked by Wall St. Rank hold ENZN as of Q4 2014.

  • Barclays reported no remaining ENZON PHARMACEUTICALS INC position as of Q4 2014 after selling out during the quarter.
  • Barclays sold 36 ENZON PHARMACEUTICALS INC shares in Q4 2014.
  • Barclays first reported a position in ENZON PHARMACEUTICALS INC in Q2 2013 and held it in 6 quarters.
  • Barclays's ENZON PHARMACEUTICALS INC position peaked at $124K in Q2 2013.
  • 57 funds tracked by Wall St. Rank held ENZON PHARMACEUTICALS INC as of Q4 2014.

Based on Barclays's 13F filing for Q4 2014, filed 13 Feb 2015.